330 related articles for article (PubMed ID: 35681707)
1. Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.
Nascente EP; Amorim RL; Fonseca-Alves CE; de Moura VMBD
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681707
[TBL] [Abstract][Full Text] [Related]
2. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases.
Cornell KK; Bostwick DG; Cooley DM; Hall G; Harvey HJ; Hendrick MJ; Pauli BU; Render JA; Stoica G; Sweet DC; Waters DJ
Prostate; 2000 Oct; 45(2):173-83. PubMed ID: 11027417
[TBL] [Abstract][Full Text] [Related]
4. Alterations in PTEN, MDM2, TP53 and AR protein and gene expression are associated with canine prostate carcinogenesis.
Rivera-Calderón LG; Fonseca-Alves CE; Kobayashi PE; Carvalho M; Drigo SA; de Oliveira Vasconcelos R; Laufer-Amorim R
Res Vet Sci; 2016 Jun; 106():56-61. PubMed ID: 27234536
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
6. p-mTOR, p-4EBP-1 and eIF4E expression in canine prostatic carcinoma.
Rivera-Calderón LG; Fonseca-Alves CE; Kobayashi PE; Carvalho M; Vasconcelos RO; Laufer-Amorim R
Res Vet Sci; 2019 Feb; 122():86-92. PubMed ID: 30476726
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis.
Pagliarone S; Frattone L; Pirocchi V; Della Salda L; Palmieri C
Res Vet Sci; 2016 Apr; 105():195-9. PubMed ID: 27033932
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
9. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
10. A Comparative in Silico Analysis of CD24's Prognostic Value in Human and Canine Prostate Cancer.
Leis-Filho AF; Lainetti PF; Franzoni MS; Palmieri C; Kobayshi PE; Laufer-Amorim R; Fonseca-Alves CE
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33806857
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer.
Laufer-Amorim R; Fonseca-Alves CE; Villacis RAR; Linde SAD; Carvalho M; Larsen SJ; Marchi FA; Rogatto SR
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925701
[TBL] [Abstract][Full Text] [Related]
12. Different Growth Patterns of Canine Prostatic Carcinoma Suggests Different Models of Tumor-Initiating Cells.
Akter SH; Lean FZ; Lu J; Grieco V; Palmieri C
Vet Pathol; 2015 Nov; 52(6):1027-33. PubMed ID: 25755134
[TBL] [Abstract][Full Text] [Related]
13. Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
de Brot S; Lothion-Roy J; Grau-Roma L; White E; Guscetti F; Rubin MA; Mongan NP
Vet Comp Oncol; 2022 Mar; 20(1):38-49. PubMed ID: 33963663
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
Palmieri C; Mancini M; Benazzi C; Della Salda L
J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
[TBL] [Abstract][Full Text] [Related]
15. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of vascular endothelial growth factor-A (VEGF-A) and its receptor in canine prostate cancer.
Leis-Filho AF; Lainetti PD; Kobayashi PE; Palmieri C; Amorim RL; Fonseca-Alves CE
Prostate; 2021 Oct; 81(14):1021-1031. PubMed ID: 34320239
[TBL] [Abstract][Full Text] [Related]
17. P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation.
Cavalca AMB; Brandi A; Fonseca-Alves RH; Laufer-Amorim R; Fonseca-Alves CE
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163087
[TBL] [Abstract][Full Text] [Related]
18. Prostatic collagen architecture in neutered and intact canines.
Ruetten H; Wegner KA; Romero MF; Wood MW; Marker PC; Strand D; Colopy SA; Vezina CM
Prostate; 2018 Aug; 78(11):839-848. PubMed ID: 29740846
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer.
Fonseca-Alves CE; Kobayashi PE; Laufer-Amorim R
Res Vet Sci; 2018 Jun; 118():365-370. PubMed ID: 29665565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
